Beta blockers, used for decades after heart attacks, provide no benefit for patients with preserved heart function, according to the REBOOT trial. The massive study also found women faced higher risks when taking the drug. Experts say the results will change heart treatment guidelines worldwide.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- Vitamin A may be helping cancer hide from the immune system
- Long COVID may be fueled by inflammation and tiny clots
- A global cancer surge is underway and the world is not ready
- MIT scientists find a way to rejuvenate the immune system as we age
- Stanford scientists uncover why mRNA COVID vaccines can trigger heart inflammation
- Eating more vitamin C can physically change your skin
- ADHD drugs don’t work the way we thought
- A new drug could stop Alzheimer’s before memory loss begins
- Study links full-fat cheese to lower dementia risk
- He ate a hamburger and died hours later. Doctors found a shocking cause
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
